Evidence map›Paper›PMID 27993826›Full record

ReviewBMJ case reports2016

Minimal change disease associated with malignant pleural mesothelioma: case report and review of the literature.

Halil Yildiz, Stoian Ioana Andreea, Delphine Hoton, Jean Cyr Yombi

Open access · greenAbstract readCase ReportsReview
In one paragraph

Review in BMJ case reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
0.3field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it, 7 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Halil YildizDepartment of Medecine Interne, Cliniques Universitaires Saint-Luc, Bruxelles, Belgium.ORCID 0000-0003-3103-1638
Stoian Ioana AndreeaDepartment of Nuclear Medicine, Cliniques Universitaires Saint-Luc, Bruxelles, Belgium.
Delphine HotonDepartment of Anatomopathology, Cliniques Universitaires Saint-Luc, Bruxelles, Belgium.
Jean Cyr YombiDepartment of Internal Medicine and Perioperative Medicine, Catholic Univ Louvain, Brussels, Belgium.
Cliniques Universitaires Saint-Luc · BEUCLouvain · BE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A 77-year-old man with a history of asbestos exposure was admitted to our internal medicine division for generalised weakness, fatigue, loss of weight, night sweats and difficulty for breathing since 3 months. Clinical examination revealed left fine crackles and bilateral leg oedema. Blood test showed elevated C reactive protein level at 142 mg/L, lactate dehydrogenase level at 421 UI, creatinine level at 5.75 mg/dL. Serum albumin level at 30 g/L, urinalysis showed significant proteinuria at 6.4 g/L. Chest X-ray showed left pleural effusion. Renal ultrasonography was normal. Thoracic CT and positron emission tomography showed mediastinal enlargement with lymphadenopathies and left pleural effusion and thickening. A pleural biopsy showed features compatible with malignant epithelioid mesothelioma. Renal biopsy showed minimal change disease and acute tubular necrosis. A diagnosis of malignant mesothelioma associated with minimal change disease and acute tubular necrosis secondary was then made. Given the poor general condition, palliative care was initiated and the patient died from respiratory failure 3 months later.

Indexed as

AgedBiopsyFatal OutcomeHumansKidneyLung NeoplasmsMaleMesotheliomaMesothelioma, MalignantNephrosis, LipoidPleuraPleural NeoplasmsPositron-Emission TomographyTomography, X-Ray Computed

Identifiers

PMID27993826
PMCPMC5174885
OpenAlexW2566004597

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.